Tumor-triggered Drug Release from Calcium Carbonate-Encapsulated Gold Nanostars for Near-Infrared Photodynamic/photothermal Combination Antitumor Therapy.

Yanlei Liu,Xiao Zhi,Meng Yang,Jingpu Zhang,Lingnan Lin,Xin Zhao,Wenxiu Hou,Chunlei Zhang,Qian Zhang,Fei Pan,Gabriel Alfranca,Yuming Yang,Jesus M. de la Fuente,Jian Ni,Daxiang Cui

DOI: https://doi.org/10.7150/thno.17602

IF: 11.6

2017-01-01

Theranostics

Abstract:Different stimulus including pH, light and temperature have been used for controlled drug release to prevent drug inactivation and minimize side-effects. Herein a novel nano-platform (GNS@CaCO3/ICG) consisting of calcium carbonate-encapsulated gold nanostars loaded with ICG was established to couple the photothermal properties of gold nanostars (GNSs) and the photodynamic properties of indocyanine green (ICG) in the photodynamic/photothermal combination therapy (PDT/PTT). In this study, the calcium carbonate worked not only a drug keeper to entrap ICG on the surface of GNSs in the form of a stable aggregate which was protected from blood clearance, but also as the a pH-responder to achieve highly effective tumor-triggered drug release locally. The application of GNS@CaCO3/ICG for in vitro and in vivo therapy achieved the combined antitumor effects upon the NIR irradiation, which was superior to the single PDT or PTT. Meanwhile, the distinct pH-triggered drug release performance of GNS@CaCO3/ICG implemented the tumor-targeted NIR fluorescence imaging. In addition, we monitored the bio-distribution and excretion pathway of GNS@CaCO3/ICG based on the NIR fluorescence from ICG and two-photon fluorescence and photoacoustic signal from GNSs, and the results proved that GNS@CaCO3/ICG had a great ability for tumor-specific and tumor-triggered drug release. We therefore conclude that the GNS@CaCO3/ICG holds great promise for clinical applications in anti-tumor therapy with tumor imaging or drug tracing.